The effect of clonidine on gastrointestinal side effects associated with ultra-rapid opioid detoxification
- PMID: 12707143
- DOI: 10.1213/01.ANE.0000060451.82578.3A
The effect of clonidine on gastrointestinal side effects associated with ultra-rapid opioid detoxification
Abstract
Clonidine, an alpha(2)-adrenergic agonist, is used to minimize withdrawal symptoms related to ultra-rapid opioid detoxification procedures. These preliminary data suggest that clonidine possesses dose-related antidiarrheal activity.
Comment in
-
Convincing effects of clonidine on neurohumoral withdrawal symptoms during antagonist-supported detoxification of opioid addicts.Anesth Analg. 2003 Nov;97(5):1548. doi: 10.1213/01.ANE.0000077670.77618.B0. Anesth Analg. 2003. PMID: 14570693 No abstract available.
References
-
- O’Conner PG, Kosten TR. Rapid and ultrarapid detoxification techniques. JAMA 1998; 279: 229–34.
-
- Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999; 353: 221–6.
-
- Lorenzi P, Marsili M, Boncinelli S, et al. Searching for a general anaesthesia protocol for rapid detoxification from opioids. Eur J Anaesthesiol 1999; 16: 719–27.
-
- Spanagel R. Is there a pharmacological basis for therapy with rapid opioid detoxification? Lancet 1999; 354: 2017–8.
-
- Nakaki T, Chang PC, Tokunaga Y, et al. Alpha 2-adrenoceptors modulating diarrhea in morphine-dependent rats. J Pharm Pharmacol 1981; 33: 397–9.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
